Tesamorelin in San Francisco, California

Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) consisting of all 44 amino acids of human GHRH with an added trans-3-hexenoic acid modification. It is FDA-approved under the brand name Egrifta for the reduction of excess abdominal fat in HIV-positive patients with lipodystrophy, making it one of the few peptides with full FDA approval for a specific indication. Tesamorelin is notable for its strong clinical evidence base, including multiple Phase III clinical trials demonstrating its efficacy for visceral fat reduction. Beyond its approved indication, it has gained significant interest in anti-aging and metabolic optimization clinics.

Our directory lists 26 peptide therapy clinics in the San Francisco, California area, many of which offer Tesamorelin protocols. When selecting a Tesamorelin provider in San Francisco, prioritize clinics with specific peptide therapy experience, transparent pricing, and proper medical oversight. Many San Francisco patients also have access to telehealth peptide providers who can offer competitive pricing and convenient consultations.